NCT05812768 (Suture-Tight™) is a NA clinical trial of Suture-Tight Suture Delivery System in Aortic Aneurysm, Abdominal, sponsored by Vesteck, Inc..

Who is sponsoring NCT05812768?

NCT05812768 is sponsored by Vesteck, Inc..

What drugs are being tested in NCT05812768?

Interventions in NCT05812768: Suture-Tight Suture Delivery System.

What condition does NCT05812768 study?

NCT05812768 studies Aortic Aneurysm, Abdominal.

Is NCT05812768 still recruiting?

NCT05812768 is currently status unknown. Last updated 16 February 2024.

Last reviewed 2024-02-16 · How we verify

NCT05812768: Suture-Tight™

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Suture-Tight™ First-in-Human Safety and Performance Study

Status unknown NA Last updated 16 February 2024

What this trial tests

NA trial testing Suture-Tight Suture Delivery System in Aortic Aneurysm, Abdominal in 6 participants. Status unknown.

Timeline

12 December 2023

Primary endpoint
19 July 2024

31 July 2024

Quick facts

Lead sponsor	Vesteck, Inc.
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	6
Start date	12 December 2023
Primary completion	19 July 2024
Estimated completion	31 July 2024
Sites	1 location across Australia

Drugs / interventions tested

Suture-Tight Suture Delivery System

Conditions studied

Aortic Aneurysm, Abdominal — all drugs for Aortic Aneurysm, Abdominal →

Sponsor

Vesteck, Inc.

Who can join

21 and older, any sex, with Aortic Aneurysm, Abdominal. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Single center, open label, prospective, single-arm, first-in-human (FIH), pre-market clinical study with the objective of validating the safety and performance of the Suture-Tight™ Suture Delivery System in an EVAR procedure.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Aortic Aneurysm, Abdominal

Currently open trials in the same condition.

NCT06488898 — Abdominal Aortic Aneurysm Stabilization With Truncal Cells: Controlled Clinical Trial With Historical Cohorts · Phase 2 · recruiting
NCT05972018 — Liposomal Bupivacaine/Bupivacaine in Rectus Sheath Blocks Versus Ropivacaine in Rectus Sheath Blocks And Catheters · Phase 4 · recruiting
NCT04503395 — ShOrt neCK AAA RAndomized Trial - ESAR and FEVAR: SOCRATES · NA · recruiting
NCT05360108 — Screening for Abdominal Aortic Aneurysm and Popliteal Artery Aneurysm · active not recruiting
NCT02489539 — Assessment of the GORE® EXCLUDER® Conformable AAA Endoprosthesis in the Treatment of Abdominal Aortic Aneurysms · NA · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05812768 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Vesteck, Inc.
Last refreshed: 16 February 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05812768.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing